Clinical Trials Browser

Phase 1/2 × Neoplasms × Rivaroxaban × Clear all

NCT03282643 2019-04-16

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Phase 1/2 Completed

Neoplasms